Touro College Announces Support for CanniCare's Medical Cannabis License Application

AIRMONT, NY – Touro College has announced that it is supporting Rockland County-based CanniCare's application for one of five media marijuana licenses to be issued by the New York State Dept. of Health (DOH).

If CanniCare is selected, Touro would provide the company with research into medicinal cannabis.

"Our college is supportive of medicinal development and research," says Alan H. Kadish, president of the Touro College System. "There is still a great deal of research to be conducted on the medical application of cannabis and we are excited by the opportunity to contribute in a meaningful way. We will also offer CanniCare advice on the clinical use of the medicine along the way."

Some of the research — to be funded from CanniCare profits — will be designed to ensure that the benefits of using medical marijuana are fully understood and that the risks are carefully considered.

"The State of New York is already working on a policy for when and how to prescribe medical cannabis, but there are always post-market refinements based on outcomes and protocols, and that's an element of the research we would conduct," Dr. Kadish says.

CanniCare's manufacturing facility will be near Stewart International Airport in Orange County. The company would operate dispensaries in Manhattan, Rockland County, Schenectady, and Rochester.

CanniCare plans to use a unique standardization technique, to which the company has access through its Canadian partner ABcann Medicinals, a world leader in plant standardization in the phytopharmaceutical industry. The process stems from intellectual properties, methods and licenses from around the world.

Standardization and being able to produce high quality medicine is the key to ensuring quality. The manufacturer must be able to reliably create and reproduce medicine within a very narrow margin of deviation, have medical manufacturing facilities standardization, and have all forms of the medicine carefully tracked and controlled, with all the genetics of one specific type.

"If we are fortunate enough to be chosen by DOH to serve New Yorkers who need this medicine, we have a responsibility to fund ongoing research so that the science and efficacy of medical marijuana continue to advance," says CanniCare CEO Joseph Zupnik. "We are honored that Touro College will be supporting us on public health initiatives in this endeavor."

Featured

  • California K–12 District Finishes Renovations on Multi-Sport Stadium

    The Alameda Unified School District (AUSD) in Alameda, Calif., recently announced the completion of a renovation project on the Encinal Jr. & Sr. High School stadium, according to a news release. The district partnered with Quattrocchi Kwok Architects (QKA) and Bothman Construction on the facility, and funding came from Bond Measure B.

  • Massachusetts K–12 District Selects Architect for New Junior High

    Swansea Public Schools in Swansea, Mass., recently announced that it has selected Finegold Alexander Architects to design a new junior high school for the district, according to a news release. The firm will create the Feasibility Study and Schematic Design for Joseph Case Junior High School after a lengthy selection process by the Massachusetts School Building Authority (MSBA).

  • 144-Year-Old High-School Campus Debuts New Academic Facility

    San Diego High School (SDHS) in San Diego, Calif., recently held a ribbon-cutting ceremony for a new student services and classroom building; the project is part of a larger SDHS Whole Site Modernization project that began in 2022.

  • DFW-Area District Opens New Replacement Middle School

    The Eagle Mountain-Saginaw Independent School District near Fort Worth, Texas, recently held a ribbon-cutting ceremony for a new replacement middle school campus, according to a news release. The new facility for Wayside Middle School, originally established in 1964, was built on the site of the former district administration building and funded through Bond Proposition A in 2023.